Company Celsion Corporation Nasdaq
Equities
US15117N3052
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Stacy Lindborg
CEO | Chief Executive Officer | 53 | 04/21/04 |
Michael Tardugno
CHM | Chairman | 73 | 03/07/03 |
Sebastien Hazard
CTO | Chief Tech/Sci/R&D Officer | 53 | 11/12 |
Khursheed Anwer
CTO | Chief Tech/Sci/R&D Officer | 64 | 20/14/20 |
Kimberly Bragg
AUD | Comptroller/Controller/Auditor | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 56 | 08/21/08 | |
Frederick Fritz
BRD | Director/Board Member | 73 | 08/11/08 |
James Dentzer
BRD | Director/Board Member | 57 | 03/22/03 |
Michael Tardugno
CHM | Chairman | 73 | 03/07/03 |
Donald Braun
BRD | Director/Board Member | 74 | 15/15/15 |
Stacy Lindborg
CEO | Chief Executive Officer | 53 | 04/21/04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 9,400,911 | 9,292,541 ( 98.85 %) | 22 ( 0.000234 %) | 98.85 % |
Company contact information
![address Celsion Corporation](https://cdn.zonebourse.com/static/address/897284.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+20.17% | 127B | |
+24.67% | 117B | |
+25.44% | 27.67B | |
-17.74% | 20.33B | |
-15.17% | 16.79B | |
-15.21% | 15.63B | |
+11.91% | 14.84B | |
-47.10% | 14.65B | |
+54.50% | 14.43B |
- Stock Market
- Equities
- IMNN Stock
- Stock
- Company Celsion Corporation